Ssengooba W, Kateete DP, Wajja A, Bugumirwa E, Mboowa G, Namaganda C, Nakayita G, Nassolo M, Mumbowa F, Asiimwe BB, Waako J, Verver S, Musoke P, Mayanja-Kizza H, Joloba ML.
Tuberc Res Treat 2012;2012:970203.
KNCV has been fighting TB since its establishment in 1903. Over the past 120 years, the organization has acquired indispensable knowledge and experience in the field of effective TB prevention and care, resulting in pre-elimination in the Netherlands and significant contributions to global evidence generation, policy development and TB program implementation worldwide.
Our experts
KNCV governance framework and integrity
Our patroness
Partner with us
Tuberculosis is still one of the major causes of preventable death in the world and claims over 4000 lives a day, leading to over 1,5 million deaths a year.
The story of Abdurahim
The story of Fikeraddis
The story of Issayas
The story of Zarina
The story of Maxine
The story of Saanvi
New drugs & treatment regimens
BPaL implementation
Digital health solutions
Diagnosis & treatment of LTBI
TB Stigma reduction
Epidemiological measurement methodologies
New diagnostics and lab network design
People-Centred Framework for National Strategic Planning and HSS
Blended learning platform & methodologies
ASCENT
ASTTIE
ETBE Project
Evaluation of SeroSelectTB
GeneXpert MTB/RIF Test
iDEFEAT TB Project
IMPAACT4C19
IMPAACT4TB
LIFT-TB
No More Pandemics
PANGenS
People-Centered Framework for TB Programming (PCF)
SMART4TB
The Global Fund to Fight AIDS, Tuberculosis and Malaria
Challenge TB
Development of a comprehensive Digital Training Package
E-detect
Improved TB/HIV Prevention & Care – Building Models for the Future Project
PAVIA
PODTEC
TB REACH Ethiopia
TB REACH Nigeria
TB REACH Philippines
TB REACH Tanzania
TREATS